Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avionord M&P was the machine and perfusion business carved out of Avionord S.r.l. in Italy and operated as XVIVO's Italian distributor focused on organ preservation and machine perfusion for transplantation. Its business combined sales of perfusion machines and disposables with education, perfusion services, and logistics support, including a CE-marked organ transport storage device called GISTO. The business generated most of its revenue from XVIVO perfusion systems and served transplant customers in the Italian market. XVIVO announced the acquisition in August 2022 and completed it in late 2022, after which the new legal entity became XVIVO S.r.l. As a result, Avionord M&P should be viewed as an acquired commercial medtech/services business rather than an independent biotech drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avionord M&P.